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Abstract
Background: Toll-like receptor 2 (TLR2) plays a critical role in mediating inflammatory/immune
responses against bacterial pathogens in lung. Streptococcus pneumoniae (S. pneumoniae) and
nontypeable Haemophilus influenzae (NTHi) were previously reported to synergize with each other
to induce inflammatory responses. Despite the relatively known intracellular signaling pathways
involved in the synergistic induction of inflammation, it is still unclear if both bacterial pathogens
also synergistically induce expression of surface TLR2.
Results: Here we provide direct evidence that S. pneumoniae synergizes with NTHi to upregulate
TLR2 expression in lung and middle ear of the mice. Pneumolysin (PLY) appears to be the major
virulence factor involved in this synergism. Moreover, S. pneumoniae PLY induces TLR2 expression
via a TLR4-MyD88-NF-κB-dependent signaling pathway. Interestingly, tumor suppressor CYLD
acts as a negative regulator of S. pneumoniae-induced TLR2 up-regulation via negative-crosstalk with
NF-κB signaling.
Conclusion: Our study thus provides novel insights into the regulation of TLR2 expression in
mixed bacterial infections.
Background
Gram-negative bacterium nontypeable Haemophilus influ-
enzae (NTHi) and gram-positive bacterium Streptococcus
pneumoniae (S. pneumoniae) are important bacterial path-
ogens causing lung infections [1,2]. In children, they
cause otitis media (OM), the most common childhood
infection and the leading cause of conductive hearing loss
[3], while in adults, they exacerbate chronic obstructive
pulmonary diseases (COPD), the fourth leading cause of
death in the United States [1,2]. Although a majority of
OM or COPD is mainly associated with a single bacterial
pathogen, there is a growing body of evidence that a por-
tion of patients diagnosed with OM or COPD have mixed
infections of NTHi and S. pneumoniae [4,5]. In the mixed
infection of NTHi and S. pneumoniae, two bacterial patho-
gens synergistically induce inflammation through activa-
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tion of specific host signaling pathway [6,7], which is
initiated through the recognition of microbial pathogens
by means of cell surface receptors.
Toll-like receptors (TLRs) are a class of pathogen recogni-
tion receptors that mediate recognition of pathogen-asso-
ciated molecular pattern. Among 13 mammalian TLRs,
TLR2 plays especially a critical role due to its capability of
detecting the widest repertoire of pathogen-associated
molecular patterns from a large variety of pathogens,
including gram-positive or gram-negative bacteria, myco-
bacteria, fungi, viruses, and parasites [8].
We previously reported that TLR2 is a key receptor recog-
nizing NTHi components [9] and is highly inducible by
multiple pro-inflammatory stimuli including NTHi itself
[9-12]. Given the fact that S. pneumoniae co-exists with
NTHi in lung and middle ear infections and synergisti-
cally enhances NTHi-induced inflammation [6], it is of
particular interest to investigate the molecular mechanism
by which TLR2 is likely induced by NTHi and S. pneumo-
niae  in a synergistic manner. In the present study, we
showed that S. pneumoniae induces TLR2 up-regulation
via a cytoplasmic pneumolysin (PLY) through a TLR4-
MyD88-NF-κB-dependent signaling pathway. Moreover,
S. pneumoniae induces expression of tumor suppressor
cylindromoatosis (CYLD), which in turn negatively regu-
lates S. pneumoniae-induced NF-κB activation and TLR2
expression. These studies thus bring new insights into syn-
ergistic regulation of host TLRs in mixed bacterial infec-
tions.
Results
S. pneumoniae pneumolysin induces TLR2 expression in 
the epithelium of lung and middle ear in vitro and in vivo
We initially investigated the effect of S. pneumoniae on
TLR2 expression in epithelial cells. As shown in Fig. 1A,
TLR2 mRNA expression was induced by S. pneumoniae
treatment in human epithelial HeLa cells in a time-
dependent manner. TLR2 expression was markedly up-
regulated at 3 h after treatment, peaked at 5 h and
declined thereafter. TLR2 up-regulation by S. pneumoniae
was also confirmed in human respiratory epithelial A549
cells (Fig. 1B). We next determined if TLR2 up-regulation
by S. pneumoniae occurs at the transcriptional level. As
shown in Fig. 1C, transcriptional activity of TLR2 pro-
moter reporter was also up-regulated by S. pneumoniae in
epithelial cells. Because pneumolysin (PLY) plays a key
role in the pathogenesis of S. pneumoniae, we investigated
whether PLY is a crucial virulence factor for the TLR2 up-
regulation by S. pneumoniae. Human respiratory epithelial
cells were treated with either S. pneumoniae WT D39 or
pneumolysin-deficient mutant PLN, and mRNA expres-
sion level of TLR2 was then measured by Q-PCR analysis.
As shown in Fig. 1D, inoculation of S. pneumoniae WT
D39 induced TLR2 mRNA expression, whereas S. pneumo-
niae  PLN did not induce it. Moreover, purified PLY
induced TLR2 expression to a similar extent to S. pneumo-
niae in middle ear HMEEC-1 epithelial cells (Fig. 1E). To
further confirm if S. pneumoniae also induces TLR2 expres-
sion in vivo, we examined S. pneumoniae- and PLY-induced
TLR2 expression in vivo using  S. pneumoniae-induced
pneumonia and OM model in mice. As shown in Fig. 1F
&1G, S. pneumoniae induced TLR2 mRNA expression in
both lung and middle ear tissues. Similar results were also
observed in PLY-inoculated mice (Fig. 1H). Consistent
with our in vitro findings, TLR2 expression was up-regu-
lated by S. pneumoniae WT D39 and PLY inoculation but
not mutant PLN (Fig. 1H). Furthermore, Western blot
analysis confirmed TLR2 up-regulation by S. pneumoniae
at the protein level after intratracheal inoculation of S.
pneumoniae in WT mice (Fig. 1I). Taken together, our data
showed that S. pneumoniae PLY induces TLR2 up-regula-
tion in lung and middle ear in vitro and in vivo.
S. pneumoniae induces TLR2 expression through TLR4-
MyD88-NF-κB-dependent signaling pathway
TLRs play a critical role in recognizing extracellular patho-
gens and transducing the cell surface interaction between
microbes and cells to intracellular components. It was
previously reported that cytolysins including Bacillus
anthracis anthrolysin O and S. pneumoniae PLY act as TLR4
agonists [13]. Moreover, we reported that PLY triggers
TLR4-dependent intracellular signaling pathway in severe
S. pneumoniae infection in lung [14,15]. Thus, we deter-
mined whether S. pneumoniae induced-TLR2 up-regula-
tion is mediated by TLR4 in vitro and in vivo. Perturbing
TLR4 signaling using TLR4 DN mutant plasmid inhibited
both S. pneumoniae-induced TLR2 promoter activity (Fig.
2A) and TLR2 mRNA expression (Fig. 2B) in vitro. To fur-
ther investigate whether TLR4 is also critical for S. pneumo-
niae-induced TLR2 up-regulation in vivo, WT and TLR4 KO
mice were intratracheally inoculated with S. pneumoniae,
and TLR2 mRNA expression was measured in the lungs of
inoculated mice. As shown in Fig. 2C, S. pneumoniae
induced TLR2 expression in the lungs of WT mice but not
TLR4 KO mice in vivo. Because MyD88 is a well-known
signaling adaptor for TLR4, we determined whether
MyD88 is required for the S. pneumoniae-induced TLR2
expression in vivo. As shown in Fig. 2D, S, pneumoniae-
induced TLR2 up-regulation was significantly reduced in
MyD88 KO mice compared to WT mice. Having demon-
strated a marked decrease in TLR2 expression in TLR4 KO
mice, we determined whether TLR4-deficiency caused this
decrease via changing bacterial clearance in the lung tis-
sues or inflammatory cell migration into airways. We
therefore measured bacteria number from the lungs of S.
pneumoniae-inoculated WT and TLR4 KO mice 24 hrs after
inoculation and also measured inflammatory cell migra-
tion into airway from the BAL fluid of vehicle- or S. pneu-BMC Immunology 2008, 9:40 http://www.biomedcentral.com/1471-2172/9/40
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S. pneumoniae induces TLR2 up-regulation via pneumolysin in the epithelium of lung and middle ear Figure 1
S. pneumoniae induces TLR2 up-regulation via pneumolysin in the epithelium of lung and middle ear. (A) Time 
dependence of TLR2 up-regulation in response to S. pneumoniae (S.p.). HeLa cells were treated with S.p. for 1, 3, 5 and 7 hours, 
and relative quantity of TLR2 mRNA expression was measured by Q-PCR analysis. (B)S.p.-induced TLR2 mRNA expression in 
lung epithelial cell A549. Cells were treated with S.p., and relative quantity of TLR2 mRNA expression was measured by Q-
PCR analysis 5 hours after treatment. (C) S.p.-induced TLR2 promoter activity. HeLa cells were transiently transfected with 
TLR2 luciferase reporter gene, treated with S.p., and relative luciferase activity was measured 5 hours after treatment. (D) The 
effects of S.p. WT strain D39 and PLY-deficient strain PLN on S.p.-induced TLR2 expression. Cells were treated either with 
S.p. D39 or PLN, and mRNA expression of TLR2 was measured by Q-PCR analysis 3 hours after treatment. (E) S.p.- and PLY-
induced TLR2 mRNA expression in middle ear cell HMEEC-1. Cells were treated with S.p. or PLY, and TLR2 mRNA expres-
sion was measured 5 hours after treatment by Q-PCR analysis. (F & G) S.p.- and PLY-induced TLR2 expressions in the lung and 
middle ear of the mice. Wild-type mice were intratracheally inoculated with S.p. or PLY for S.p.-induced pneumonia (F) and 
inoculated into the middle ear through tympanic membrane for S.p.-induced otitis media model (G). Relative quantity of TLR2 
mRNA was measured from the lungs of inoculated mice 3 hours after inoculation and from the middle ears of inoculated mice 
9 hours after inoculation. (H) The effect of PLY on S.p.-induced TLR2 expression was measured using S.p. WT strain D39 and 
PLY-deficient strain PLN in mice in vivo. WT mice were intratracheally inoculated with S.p. D39 or PLN, or purified PLY, and 
TLR2 mRNA expression was measured from the lungs of inoculated mice 9 hours after inoculation by Q-PCR analysis. (I) Pro-
tein expression of TLR2 is up-regulated following S.p. infection. TLR2 protein expression was measured from the lungs WT 
mice inoculated with S.p. by western blotting analysis 6 hours after inoculation (left panel), and band data was analyzed using 
Kodak Image analysis system and data was presented as Fold induction (right panel). Data are means ± S.D. (n = 3). *, p < 0.05 
compared with CON, **, p < 0.01 compared with CON, ***, p < 0.05 compared with S.p. D39, CON, control.BMC Immunology 2008, 9:40 http://www.biomedcentral.com/1471-2172/9/40
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TLR4-MyD88-NF-κB signaling pathway mediates S. pneumoniae-induced TLR2 up-regulation Figure 2
TLR4-MyD88-NF-κB signaling pathway mediates S. pneumoniae-induced TLR2 up-regulation. (A) Cells were tran-
siently transfected with TLR2 promoter reporter gene with TLR4 DN mutant plasmid or empty vector, and S.p.-induced luci-
ferase activity was measured 5 hours after S.p. treatment. (B) Cells were transiently transfected either with TLR4 DN mutant 
plasmid or empty vector, and S.p.-induced TLR2 mRNA expression was measured by Q-PCR analysis. (C) WT and TLR4 KO 
mice were intratracheally inoculated with S.p., and TLR2 mRNA expression was measured from the lungs of inoculated mice by 
Q-PCR analysis. (D) WT and MyD88 KO mice were intratracheally inoculated with S.p., and TLR2 mRNA expression was 
measured from the lungs of inoculated mice by Q-PCR analysis. (E) Bacterial number in the lungs of WT and TLR4 KO mice 
following S.p. inoculation. WT and TLR4 KO mice were intratracheally inoculated with 1 × 107 CFU of S.p. D39, and CFU of 
the lungs were measured 24 hours after inoculation. (F) Inflammatory cell migration into airway in WT and TLR4 KO mice fol-
lowing S.p. inoculation. WT and TLR4 KO mice were intratracheally inoculated with 1 × 107 CFU of S.p., and total cells were 
measured from the BAL fluid of the lungs of saline- or S.p.-inoculated mice 6 hours after inoculation. (G & H) Cells were trans-
fected with NF-κB reporter gene, and S.p.- or PLY-induced NF-κB promoter activity was measured as relative luciferase activ-
ity. (I & J) Cells were transiently transfected with IκBα DN, IKKα DN, IKKαsiRNA, empty vector, or control siRNA, and S.p.-
induced TLR2 mRNA expression was measured by Q-PCR analysis. Data in A-D & G-J are means ± S.D. (n = 3). *, p < 0.05 
compared with CON, **, p < 0.05 compared with S.p. in MOCK or WT mice, CON, control inoculated with vehicle.BMC Immunology 2008, 9:40 http://www.biomedcentral.com/1471-2172/9/40
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moniae-inoculated WT and TLR4 KO mice 6 hrs after
inoculation (Fig. 2E &2F). Neither bacteria number of the
lungs nor inflammatory cell migration into airways in
TLR4 KO mice was significantly different from those in
WT mice. The results reported herein demonstrate that,
under the conditions reported here, TLR4-deficiency does
not affect the bacterial clearance of S. pneumoniae and
inflammatory cell migration response to S. pneumoniae,
and decrease in S. pneumoniae-induced TLR2 expression in
TLR4 KO mice is independent of both bacteria number
and inflammatory cells in the lung in vivo. Collectively,
our data suggest that S. pneumoniae induces TLR2 up-reg-
ulation via TLR4-MyD88 signaling pathway.
Because NF-κB plays an important role in mediating PLY-
induced host responses, we next determined if NF-κB is
also involved in mediating TLR2 up-regulation by PLY
[9,10,16]. As shown in Fig. 2G &2H, S. pneumoniae
induced NF-κB activation in a dose-dependent manner.
Similar result was also observed in PLY-treated cells. We
further determined the involvement of IKKα-IκBα, the key
signaling pathway upstream of NF-κB, in TLR2 induction
[6,14]. As shown in Fig. 2I, perturbing IKKα and IκBα sig-
naling by overexpressing DN mutant plasmid inhibited S.
pneumoniae-induced TLR2 mRNA up-regulation. This
finding was further confirmed by using IKKαsiRNA (Fig.
2J). Thus it is clear that S. pneumoniae-induced TLR2 up-
regulation is mediated by IKKα and IκBα-dependent NF-
κB activation.
S. pneumoniae induced-TLR2 up-regulation is negatively 
regulated by tumor suppressor CYLD
Bacteria modulates many innate immune responses via
induction of negative regulatory molecules [15,17,18].
We previously reported that S. pneumoniae induces tumor
suppressor CYLD, an important negative regulator of NF-
κB signaling pathway, in severe S. pneumoniae infection
[15]. NTHi induced CYLD expression, which in turn leads
to negative regulation of NTHi-induced NF-κB-dependent
inflammation [19]. CYLD expression is relatively low in
lung but is highly induced under diseased condition [18].
To determine the role of CYLD in S. pneumoniae-induced
TLR2 expression in the lung and middle ear, we first eval-
uated up-regulation of CYLD in vitro. As shown in Fig. 3A,
S. pneumoniae induced CYLD expression not only in lung
epithelia cell A549, but also in middle ear epithelial cell
HMEEC-1. To further confirm whether S. pneumoniae
induces CYLD both in the lung and middle ear in vivo, WT
mice were intratracheally or transtympanically inoculated
with S. pneumoniae, and CYLD mRNA expression was then
measured in the lung and middle ear tissues of inoculated
mice, respectively. As shown in Fig. 3B, S. pneumoniae
induced CYLD expression in both lung and middle ear of
the mice.
To further investigate the role of CYLD in S. pneumoniae-
induced NF-κB activation, the effect of CYLD knockdown
using CYLD siRNA was measured. As shown in Fig. 3C. S.
pneumoniae- and PLY-induced NF-κB promoter activity
was greatly enhanced by CYLD siRNA. To investigate
whether CYLD acts as a negative regulator for S. pneumo-
niae-induced TLR2 expression, the effects of CYLD siRNA
on S. pneumoniae-induced TLR2 mRNA expression were
measured. As shown in Fig. 3D, knockdown of CYLD
expression using CYLD siRNA greatly enhanced S. pneu-
moniae-induced TLR2 mRNA expression. To determine the
in vivo role of CYLD on S. pneumoniae-induced TLR2
expression, we measured TLR2 mRNA expression in lung
tissues of WT and CYLD KO mice after S. pneumoniae inoc-
ulation. Consistent with our in vitro findings, S. pneumo-
niae-induced TLR2 mRNA up-regulation was enhanced in
CYLD KO mice (Fig. 3E). Together, our data indicate that
CYLD acts as a negative regulator for S. pneumoniae-
induced NF-κB activation and TLR2 up-regulation.
S. pneumoniae synergizes with NTHi to induce 
inflammatory response via TLR2
To determine whether S. pneumoniae synergizes with
NTHi to induce inflammatory response, we investigated
the effect of S. pneumoniae and NTHi on the expression of
IL-1β, a key NF-κB-dependent pro-inflammatory cytokine
in lung and middle ear. As shown in Fig. 4A, S. pneumoniae
and NTHi synergistically enhanced expression of IL-1β ?
mRNA in human lung epithelial cell. Moreover, S. pneu-
moniae and NTHi also synergistically induced expression
of IL-1β mRNA in the lungs of mice (Fig. 4B). Next we
investigated the role of TLR2 in synergistic induction of
NF-κB-dependent inflammatory response by S. pneumo-
niae  and NTHi. As shown in Fig. 4C, siRNA mediated
knockdown of TLR2 markedly inhibited synergistic induc-
tion of IL-1β mRNA expression by S. pneumoniae and
NTHi, thereby providing evidence for the involvement of
TLR2 in this synergistic induction. This finding was fur-
ther confirmed in the cells from TLR2 KO mice in vitro
(Fig. 4D). Having shown that S. pneumoniae-induced TLR2
up-regulation is inhibited by TLR4-deficiency, and TLR2
up-regulation is closely associated with synergistic
response by S. pneumoniae with NTHi, we determined if
TLR4-deficiency affects synergistic activation of NF-κB
and subsequent gene expression by S. pneumoniae with
NTHi. We first measured NF-κB activation and mRNA
expressions of TLR2 and IL-1β following co-treatment
with S. pneumoniae and NTHi in cells (Fig. 4E) and lung
tissues (Fig. 4F &4G) of WT and TLR4 KO mice. As shown
in Fig. 4E, NF-κB activation by S. pneumoniae with or with-
out NTHi was significantly decreased in the cells from
TLR4 KO mice compared with those in cells from WT mice
(Fig. 4E). In addition, mRNA expressions of TLR2 and IL-
1β by S. pneumoniae with or without NTHi in the lung tis-
sues of TLR4 KO mice were also significantly decreasedBMC Immunology 2008, 9:40 http://www.biomedcentral.com/1471-2172/9/40
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compared with those in WT mice (Fig. 4F &4G). Taken
together, these findings suggest that S. pneumoniae syner-
gizes with NTHi to induce NF-κB activation and subse-
quent gene expression via TLR2 up-regulation.
Discussion
There is a growing body of evidence showing that a por-
tion of patients diagnosed with OM or COPD have mixed
infections of NTHi and S. pneumoniae [4,5]. Under in vivo
situations such as polymicrobial infections, mucosal epi-
thelial surfaces are simultaneously exposed to a variety of
bacteria and bacterial components, and one microbe syn-
ergizes with another one to induce the inflammatory
response by activating intracellular signaling pathway
[6,7]. Among many other innate immune components,
TLRs are critical for initiating and mediating immune
response. Thus, regulation of TLRs expression plays an
important role in modulating host response to microbes.
However, little is known about the molecular mecha-
nisms underlying regulation of TLRs expression in mixed
infection.
As we previously reported, TLR2 expression is relatively
low in unstimulated epithelial cells but is markedly up-
regulated in response to invading microbes [10,11]. How-
ever, the link between TLR2 up-regulation and mixed
CYLD negatively regulates S. pneumoniae-induced TLR2 up-regulation Figure 3
CYLD negatively regulates S. pneumoniae-induced TLR2 up-regulation. (A) Human alveolar epithelial cell A549 and 
human middle ear epithelial cell HMEEC-1 were treated with S.p., and CYLD mRNA expression was measured 5 hours after 
treatment by Q-PCR analysis. (B) WT mice were intratracheally or transtympanically inoculated with S.p. for pneumonia and 
otitis media model, respectively, and CYLD mRNA expression was measured from the lungs and middle ear tissues of inocu-
lated mice 3 hours after inoculation and 9 hours after inoculation, respectively. Data in A & B are means ± S.D. (n = 3). *, p < 
0.05 compared with CON, CON, control treated with vehicle. (C) Cells were transfected with NF-κB reporter gene with 
CYLD siRNA or empty vector. S.p.- or PLY-induced NF-κB promoter activity was measured as relative luciferase activity. (D) 
Cells were transfected either with CYLD siRNA or empty vector, and S.p.-induced TLR2 mRNA expression was measured 5 
hours after treatment by Q-PCR analysis. (E) WT and CYLD KO mice were intratracheally inoculated with S.p., and TLR2 
mRNA expression was measured from the lungs of inoculated mice 6 hours after inoculation by Q-PCR analysis. Data are 
means ± S.D. (n = 3). *, p < 0.05 compared with CON, **, p < 0.05 compared with S.p. in MOCK (A-C) or in WT mice (D), 
CON, control inoculated with vehicle, MOCK, transfected with empty vector.BMC Immunology 2008, 9:40 http://www.biomedcentral.com/1471-2172/9/40
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S. pneumoniae synergizes with NTHi to induce inflammatory response by up-regulating TLR2 expression Figure 4
S. pneumoniae synergizes with NTHi to induce inflammatory response by up-regulating TLR2 expression. (A) 
HeLa cells were treated with S.p. with or without NTHi, and IL-1β mRNA expression was measured 5 hours after treatment 
by Q-PCR analysis. (B) WT mice were intratracheally inoculated with S.p. with or without NTHi, and IL-1β mRNA expression 
was measured from the lungs of inoculated mice 6 hours after inoculation by Q-PCR analysis. (C) Cells were transfected with 
TLR2 siRNA or control siRNA, treated with S.p. with or without NTHi, and IL-1β mRNA expression was measured 5 hours 
after infection by Q-PCR analysis. (D) NF-κB luciferase activity following S.p., NTHi, or S.p. with NTHi in MEF cells from WT 
and TLR2 KO mice. MEF cells from WT and TLR2 KO mice were transfected with NF-κB reporter gene, inoculated with S.p., 
NTHi, or S.p. with NTHi, and relative luciferase activity was measured 5 hours after inoculation. (E) NF-κB luciferase activity 
following S.p., NTHi, or S.p. with NTHi in MEF cells from WT and TLR4 KO mice. MEF cells from WT and TLR4 KO mice 
were transfected with NF-κB reporter gene, inoculated with S.p., NTHi, or S.p. with NTHi, and relative luciferase activity was 
measured 5 hours after inoculation. (F & G) TLR2 and IL-1β up-regulation in the lungs of WT and TLR4 KO mice following S.p., 
NTHi, or S.p. with NTHi in vivo. WT and TLR4 KO mice were intratracheally inoculated with S.p., NTHi, or S.p. with NTHi, 
and TLR2 (F) and IL-1β (G) mRNA expression was measured from the lung of inoculated mice 6 hours after inoculation. Data 
are means ± SD (n = 3). *, p < 0.05 compared with control, **, p < 0.05 compared with NTHi treatment, ***, p < 0.05 com-
pared with S.p. with NTHi treatment in MOCK or WT mice.BMC Immunology 2008, 9:40 http://www.biomedcentral.com/1471-2172/9/40
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infection in otitis media and pneumonia still remains
unknown. From what we have shown in the present data,
it is evident that TLR2 expression is up-regulated by S.
pneumoniae via a TLR4-MyD88-NF-κB-dependent signal-
ing pathway through its well-known virulence factor PLY.
We further show that S. pneumoniae and NTHi synergize
with each to induce NF-κB activation and IL-1β expression
dependently of TLR2 up-regulation. In the present study,
we provided evidence for the first time that S. pneumoniae
synergizes with NTHi to induce NF-κB-dependent inflam-
matory response likely via TLR2 up-regulation in lung and
middle ear epithelia cells, thereby bringing new insight
into our understanding of the complex regulatory mecha-
nisms underlying inflammation in polymicrobial infec-
tions.
In addition to TLR2 and TLR4, TLR1, 6, and 9 have also
been shown to be involved in S. pneumoniae infection [20-
22]. Therefore we evaluated lung epithelial cell expression
of 10 TLRs (TLR1-10) and CD14, MyD88, MD1 and 2 fol-
lowing  S. pneumoniae treatment in A549 cells. In
untreated cells, the expression level of TLR1, 3, 4, 5, 6 and
9 was relatively high compared to those of TLR2, 7, and 8.
Interestingly, the expression of TLR2, 7 and 8 at the mRNA
level was highly up-regulated following S. pneumoniae
treatment (Data not shown), implying a possible impor-
tant role for TLR2 up-regulation in bacterial infections.
Indeed, the data we presented in this study demonstrated
that the synergistic activation of NF-κB and inflammation
by S. pneumoniae and NTHi is dependent on TLR2 up-reg-
ulation.
Although there is strong evidence to support that TLR4 is
a critical receptor for recognizing pneumolysin and pneu-
molysin is a major virulence factor of pneumococcal
infection, the role of TLR4 in pneumococcal infection is
not fully understood [23-26]. It remains somewhat con-
troversial whether TLR4-deficiency confers susceptibility
or tolerance to pneumococcal infection in vivo
[23,24,27,28]. Controversial phenotype of TLR4-defi-
ciency mice in S. pneumoniae infection may be partly due
to the strain differences of the mice used in each experi-
ment, e.g. using C3H/HeJ, BALB/c and C57BL/6 as back-
ground strains. It is well known that different mouse
strains exhibit a very different susceptibility to pneumo-
coccal infection [28-30]. BALB/c mice, which were used as
a background strain of TLR4 KO mice in our current exper-
iment, were known as resistant strain in pneumococcal
infection compared to other strains [30]. TLR4-deficiency
in this strain thus may have no significant effect on pneu-
mococcal clearance.
Another interesting finding in this study is the experimen-
tal evidence for the negative regulation of S. pneumoniae-
induced TLR2 up-regulation by tumor suppressor CYLD.
CYLD was previously identified as an important regulator
not only in tumor development [31,32] but also in adap-
tive immune response [33,34]. Recent evidence demon-
strated that CYLD also serves as a key regulator for innate
immune response via negative-crosstalk with MAPKs and
NF-κB [15,17,19,32]. Moreover we recently identified an
important role for CYLD in modulating host antiviral
response by regulating TLR7 expression in mixed infec-
tion of bacteria and virus [35]. However, still unknown is
how CYLD regulates inflammatory response in mixed
bacterial infection.
Conclusion
In the present study we showed for the first time that S.
pneumoniae synergizes with NTHi to induce NF-κB activa-
tion and the subsequent inflammatory response via up-
regulation of TLR2. Moreover, we showed that S. pneumo-
niae-induced TLR2 up-regulation is mediated by TLR4-
MyD88-IKKα-IκBα signaling pathway. Interestingly,
tumor suppressor CYLD acts as a negative regulator for the
synergistic induction of inflammation by S. pneumoniae
and NTHi, thereby implying a critical role for CYLD in
preventing overactive inflammatory response in mixed
infections. This study may bring new insights into the
molecular mechanisms underlying polymicrobial infec-
tions, especially mixed infection of gram-positive and
negative bacteria.
Methods
Cell cultures
Human alveolar epithelial cell line A549, human middle
ear epithelia cell line HMEEC-1 derived by human papil-
lomavirus immortalization of primary human middle ear
epithelial cell, and human cervix epithelia cell line HeLa
were maintained as described previously [6,9-12]. Mouse
embryonic fibroblasts (MEFs) were isolated from E13
embryos of WT, TLR2 KO and TLR4 KO mice and cultured
in DMEM.
Bacteria and pneumolysin
Clinical isolates of S. pneumoniae WT D39, and D39 iso-
genic PLY-deficient mutant PLN were used in both in vitro
and in vivo experiments [36]. S. pneumoniae was grown on
chocolate agar plates and in Todd-Hewitt broth supple-
mented with 0.5% yeast extract (THY) at 37°C in a
humidified 5% CO2  water-jacketed incubator without
shaking. Mid-log phase bacterial culture was used in the
experiments. S. pneumoniae was inoculated at the concen-
tration of 1 × 106 or 1 × 107 colony forming unit (CFU) in
both in vitro and in vivo experiments unless otherwise spe-
cifically indicated in the figures and figure legends. Native
PLY was described previously [25] and treated/inoculated
at the concentration of 100 ng/ml. NTHi strain 12, a clin-
ical isolate, was used in this study. NTHi was inoculated at
the concentration of 1 × 107 CFU in both in vitro and inBMC Immunology 2008, 9:40 http://www.biomedcentral.com/1471-2172/9/40
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vivo experiments. The preparation of bacterial lysate was
described previously [10,14].
Animal and animal experiments
C57BL/6 and BALB/c mice were purchased from Charles
River. TLR4 KO mice were purchased from Jackson Lab.,
and TLR2 and MyD88 KO mice were kindly provided by
Dr. S. Akira. CYLD KO mice were reported previously [15].
For the S. pneumoniae or PLY-induced pneumonia model
in mice, animals were intratracheally inoculated with 1 ×
107 CFU of S. pneumoniae or 100 ng of PLY in 50 μl of
saline. At the time point indicated in the figure legends,
mice were sacrificed by overdose injection of sodium
pentobarbital, and mRNA expressions of TLR2, CYLD,
and IL-1β were measured in the lung tissues of control
and S. pneumoniae or PLY-inoculated mice as described
below. For the S. pneumoniae or PLY-induced OM model
in mice, animals were inoculated with S. pneumoniae or
PLY in 10 μl of saline via transtympanic inoculation. Nine
hours after inoculation, animals were sacrificed by over-
dose injection of sodium pentobarbital, and middle ears
were dissected from the skull for extraction of mRNA for
measuring TLR2 and CYLD expression. For the control
inoculation in both pneumonia and OM model, 50 μl or
10 μl of saline was inoculated, respectively. All animal
experiments were approved by the Institutional Animal
Care and Use Committee at University of Rochester.
Transfection and small interfering RNA (siRNA)
The expression plasmids including TLR4 dominant-nega-
tive (DN) mutant, IκBα DN (S32/36A), IKKα DN
(K44M), and NF-κB and TLR2 luciferase reporters were
described previously [6,9-12]. RNA-mediated interference
for down-regulating CYLD, IKKα, and TLR2 expression
was conducted using small interfering CYLD siRNA (pSu-
per-CYLD), IKKαsiRNA (Dharmacon), and TLR2 siRNA
(Dharmacon) as described previously [17]. All transient
transfections of plasmids were carried out using TransIT-
LT1 (Mirus), and RNA-mediated interferences were car-
ried out using Lipofectamine™ 2000 (Invitrogen) follow-
ing the manufacturer's instructions.
Real-time quantitative PCR (Q-PCR) analysis
Q-PCR analysis of TLR2, CYLD, and IL-1β was conducted
as follows. Total RNA was isolated from cells and lung and
middle ear tissues of mice using TRIzol (Invitrogen) fol-
lowing the manufacturer's instruction. RT reaction was
conducted using TaqMan reverse transcription reagents
(ABI) following the manufacturer's instruction. PCR
amplification was performed with TaqMan universal mas-
ter mix (ABI) for TLR2 and IL-1β and SYBR green universal
master mix (ABI) for CYLD. Predeveloped human and
mouse TLR2 and IL-1β Q-PCR primers were purchased
from ABI, and primer sequences for human and mouse
CYLD are as follows: human CYLD sense, 5'-ttc agc ctg ttt
aaa aac aga aa-3'; human CYLD antisense, 5'-tcc cca gga cct
gcg taa t-3'; mouse CYLD sense, 5'-ctc agc cta ttt aga aac
aga ct-3'; mouse CYLD antisense, 5'-tct cct ggg cct gca aat-
3'. Reactions were amplified and quantified using an ABI
7500 sequence detector and manufacturer's software
(ABI). The relative quantity of TLR2, CYLD, and IL-1β
mRNA was obtained using the comparative CT method
and was normalized using predeveloped TaqMan assay
reagent human cyclophilin and mouse GAPDH as an
endogenous control for human mRNA and mouse
mRNA, respectively.
Western Blotting analysis
Antibody against TLR2 was purchased from eBioscience,
and Western blot analysis of TLR2 was conducted as fol-
lows. WT mice were first intratracheally inoculated with 1
× 107 CFU of S. pneumoniae and total protein was then
extracted from the lung tissues of saline- or S. pneumoniae-
inoculated mice 6 hours after inoculation. Western blot
analysis was performed as described previously
[10,14,37].
Statistical analysis
Statistical analysis was performed with student t-test. P
values of less than 0.05 were considered statistically sig-
nificant.
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time quantitative RT-PCR.
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